Peptide Centre Launches in Hyderabad

Sai Life Sciences, a leading contract research, development, and manufacturing organization (CRDMO), has unveiled its dedicated Peptide Research Centre at its integrated R&D campus in Hyderabad. This strategic move is designed to meet the increasing demand for complex peptide synthesis and conjugation within the pharmaceutical industry.

The new centre will support innovator pharma and biotech companies by offering advanced capabilities in peptide synthesis, discovery, and cutting-edge modalities such as complex conjugates. The facility is equipped with state-of-the-art automation, robotics, advanced liquid handling, and high-throughput systems, all aimed at improving precision, scalability, and efficiency in developing novel peptide-based therapeutics. According to Maneesh Pingle, Head of Discovery Services at Sai Life Sciences, the demand for peptide-based therapeutics is growing due to their superior specificity, biocompatibility, and reduced off-target effects.

Fully integrated with Sai Life Sciences' comprehensive discovery services—including synthetic and medicinal chemistry, biology, and toxicology—the Peptide Research Centre offers a seamless transition across various stages of drug discovery, boosting success rates.

This expansion further solidifies Sai Life Sciences' role as a trusted partner for global pharmaceutical companies, providing innovative peptide solutions for the development of next-generation drugs.

News by Rahul Yelligetti.